Esperion Therapeutics, Inc.
ESPRDelisted Jul 13, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434868
Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Esperion Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 176 | 2 | 184 | +10 |
| Shares | 137.0M | 14.0M | 129.5M | +6.49M (+5.3%) |
| Value | $304.2M | $31.0M | $214.3M | −$58.9M (−21.5%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (22)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Great Point Partners LLC | 5,791,594 | $12.9M |
| Whitefort Capital Management, LP | 2,299,121 | $5.10M |
| Gsa Capital Partners LLP | 813,399 | $1.81M |
| Jacobs Levy Equity Management, Inc | 595,016 | $1.32M |
| CWM Advisors, LLC | 341,223 | $757.5K |
| Alpine Global Management, LLC | 183,922 | $408.3K |
| Point72 Asset Management, L.P. | 67,070 | $148.9K |
| Deerfield Management Company, L.P. (Series C) | 66,588 | $147.8K |
| Midland Wealth Advisors LLC | 60,000 | $133.2K |
| Baader Bank INC | 60,216 | $131.5K |
| Oxford Asset Management LLP | 42,161 | $93.6K |
| Marathon Trading Investment Management LLC | 31,070 | $69.0K |
| Stifel Financial Corp | 28,915 | $64.2K |
| Castleview Partners, LLC | 27,374 | $60.8K |
| American Century Companies Inc | 22,518 | $50.0K |
| Dynamic Technology Lab Private Ltd | 17,007 | $38.0K |
| Simplicity Wealth,LLC | 16,395 | $36.4K |
| Polymer Capital Management (HK) LTD | 12,755 | $28.3K |
| Wetzel Investment Advisors, Inc. | 5,000 | $13.4K |
| Anchor Investment Management, LLC | 6,000 | $13.3K |
| Signaturefd, LLC | 342 | $759 |
| Comerica Bank | 15 | $33 |
Not filed for Q3 2024 yet (2)
Institutions that held Esperion Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 13,983,662 | $31.0M |
| Benjamin F. Edwards & Company, Inc. | 325 | $1.00K |